GlaxoSmithKline China charges update
CNBC's Eunice Yoon discusses the damage control coming out of GlaxoSmithKline, which says the charges out of China were disappointing and the company is commissioning its own review.
02:14
Wed, Jul 24 20137:47 AM EST
Top Videos
- Subscribe to CNBC PRO
- Licensing & Reprints
- Join the CNBC Panel
- Supply Chain Values
- Advertise With Us
- Closed Captioning
- Digital Products
- Terms of Service
- Privacy Policy
- News Releases
- Internships
- Corrections
- About CNBC
- AdChoices
- Site Map
- Podcasts
- Contact
- Careers
- Help
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Get this delivered to your inbox, and more info about our products and services. Privacy Policy.
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by 